TDC
ALBO

Thompson Davis & Co’s Albireo Pharma Inc ALBO Stock Holding History

Thompson Davis & Co’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$42K Sell
1,262
-125
-9% -$4.09K 0.09% 228
2018
Q2 		$49K Sell
1,387
-125
-8% -$4.05K 0.12% 195
2018
Q1 		$49K Buy
1,512
+1,292
+587% +$43.5K 0.13% 174
2017
Q4 		$6K Buy
+220
New +$5.58K 0.01% 508

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Thompson Davis & Co's ALBO Position: Q3 2018 in Review

Thompson Davis & Co reduced its Albireo Pharma Inc (ALBO) stake by 9% in Q3 2018, selling an estimated $4.09K and leaving 1,262 shares worth $42K. The position accounts for 0.09% of the portfolio, ranked #228.

Thompson Davis & Co first reported a position in ALBO in Q4 2017 and has held it in 4 quarters since. The position peaked at $49K in Q2 2018. 67 funds tracked by Wall St. Rank hold ALBO as of Q3 2018.

  • Thompson Davis & Co held 1,262 shares of Albireo Pharma Inc worth $42K as of Q3 2018.
  • Thompson Davis & Co sold 125 Albireo Pharma Inc shares in Q3 2018, an estimated $4.09K.
  • Albireo Pharma Inc made up 0.09% of Thompson Davis & Co's portfolio in Q3 2018, its #228 holding.
  • Thompson Davis & Co first reported a position in Albireo Pharma Inc in Q4 2017 and has held it in 4 quarters since.
  • Thompson Davis & Co's Albireo Pharma Inc position peaked at $49K in Q2 2018.
  • 67 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.